Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

69.25EUR
11:35am EST
Change (% chg)

€-0.45 (-0.65%)
Prev Close
€69.70
Open
€70.01
Day's High
€70.10
Day's Low
€69.09
Volume
5,561
Avg. Vol
9,670
52-wk High
€102.07
52-wk Low
€61.22

ALCAR.PA

Chart for ALCAR.PA

About

Carmat SAS is a France-based Company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The Company formed a network of partnerships with hospitals and various scientific... (more)
No analyst recommendations are available for ALCAR.PA.

Overall

Beta: 1.62
Market Cap(Mil.): €298.56
Shares Outstanding(Mil.): 4.28
Dividend: --
Yield (%): --

Financials

  ALCAR.PA Industry Sector
P/E (TTM): -- 35.15 40.64
EPS (TTM): -4.53 -- --
ROI: -238.55 10.61 18.12
ROE: -1,201.35 12.35 18.97
Search Stocks

BRIEF-Carmat Subscribes to new equity line with Kepler Cheuvreux

* Announces to take out a new contingent equity line with Kepler Cheuvreux

26 Jan 2015

Carmat to sell up to 50 million euros worth of shares

PARIS, Jan 26 - France's Carmat SA plans to sell up to 50 million euros ($56 million) of shares in three blocs to help it finance ongoing clinical trials of its artificial heart.

26 Jan 2015

BRIEF-Carmat will benefit from European Seed1 program

* Will benefit from the European Seed1 program that supports therapy developers seeking reimbursement Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

22 Jan 2015

Shares in artificial heart maker Carmat up 18 pct after successful operation

PARIS, Jan 19 - Carmat shares gained nearly a fifth on Monday after the French artificial heart manufacturer said a patient fitted with one of its devices had been discharged from hospital.

19 Jan 2015

BRIEF-Patient with Carmat bioprosthetic heart discharged home

* Announces that the patient implanted at the Nantes University Hospital in August 2014 has been discharged from the hospital and has returned home

19 Jan 2015

French company Carmat fits second patient with artificial heart

PARIS - French company Carmat said on Monday it had fitted a second patient with one of its artificial hearts and would continue clinical trials on two more patients.

08 Sep 2014

UPDATE 2-French company Carmat fits second patient with artificial heart

* Two more patients will be fitted with the device (Adds health ministry statement, analyst comment)

08 Sep 2014

Carmat fits a second patient with its artificial heart

PARIS - French company Carmat confirmed on Monday that it had fitted a second patient with one of its artificial hearts and would continue its clinical trials on two more patients.

08 Sep 2014

Carmat's second patient was implanted on August 5: health ministry

PARIS - An artificial heart made by Carmat was fitted into a second patient on Aug 5 and the operation went smoothly, the French health ministry said in a statement on Monday.

08 Sep 2014

Carmat's second patient was implanted on Aug 5 -health ministry

PARIS, Sept 8 - An artificial heart made by Carmat was fitted into a second patient on Aug 5 and the operation went smoothly, the French health ministry said in a statement on Monday.

08 Sep 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks